Specialty Providers
Reliant Infusion plots expansion across new markets
October 23, 2026Theresa Flaherty
CHICAGO – Reliant Infusion’s omni-channel model of specialty infusion services is the platform’s biggest competitive advantage as it positions for growth, says Shore Capital Partners, its parent company.
“We believe in having a scaled business with a diverse (population) of patients tailored to as many end markets as we possibly can,” said AJ Gauthier, principal at Shore Capital. “We started with the framework of (wanting to be) in multiple states, and we’ve...
CGM benefits ripple beyond glucose control, study finds
October 23, 2026Theresa Flaherty
ABBOTT PARK, Ill. – Continuous glucose monitoring (CGM) is increasingly recognized as a powerful tool for managing diabetes, but new research from Abbott suggests its impact may extend much further. The company recently published a study that found CGM use was associated with a lower risk of death and cardiovascular complications among adults with Type 2 diabetes using basal insulin.
Study author Dr. Jay Shubrook spoke with HME News about what may be driving the improved outcomes, how CGM...
Abbott to separate Nutrition business, position it to scale
October 22, 2026HME News Staff
ABBOTT PARK, Ill. – Abbott plans to separate its nutrition business into an independent, publicly traded company with approximately $8.5 billion in annual sales.
"As we continue to shape Abbott for the future, this separation will benefit both companies, setting each one up for maximum success in its respective market," said Robert B. Ford, chairman and CEO, Abbott. "Our Nutrition business has a unique opportunity to capitalize on the growing demand for healthy nutrition,...
Study: CGM use can improve diabetes management for Type 2 patients
October 15, 2026HME News Staff
AURORA, Colo. – Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with Type 2 diabetes who don't take insulin, according to findings from new research published in the New England Journal of Medicine.
The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below...
New NCPA Digest offers updated outlook for indie pharmacies
October 5, 2026HME News Staff
KANSAS CITY, Mo. – Independent community pharmacies represent nearly 37% of all retail pharmacies in the United States, according to the 2026 NCPA Digest, which was released as part of the National Community Pharmacists Association’s Annual Convention, Oct. 3-6 in Kansas City, Mo.
The NCPA points out that it continues to be true that no single pharmacy has more stores than all independent pharmacies combined.
“Independent pharmacies continue to be resilient and providing health...
Dexcom reports on access, attitudes to diabetes technology
September 29, 2026HME News Staff
MILAN – A majority of health care providers (HCPs) recognize continuous glucose monitoring (CGM) as essential to Type 2 diabetes management, according to a new report published by Dexcom ahead of the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan Sept. 28-Oct. 2.
Eighty-nine percent of HCPs believe CGM helps them assess treatment adherence between appointments, and more than half of current CGM users report they have followed their treatment plan...
Medically Modern builds scale through practice partnerships, payer access
September 25, 2026HME News Staff
NEW YORK – Medically Modern is in growth mode with a new model that uses its insurance expertise and customized technology to help physicians better manage their diabetes patients, says founder and CEO Corey Deutsch.
Medically Modern recently announced a new partnership with an independent, multi-location endocrinology practice in Northern Virginia to manage prior authorization and fulfillment for its continuous glucose monitor (CGM) and insulin pump referrals.
‘We speak fluent...
KabaFusion taps CareCloud to build end-to-end platform
September 18, 2026Theresa Flaherty
LEXINGTON, Mass. – It’s the right time for a new platform to power KabaFusion’s operations and the company’s new partnership with CareCloud provides an opportunity to build it with all the “bells and whistles,” says CEO Dr. Sohail Masood.
KabaFusion and CareCloud announced in August that they’re working together to create LailaCare, an artificial intelligence (AI)-powered platform that will provide end-to-end operational and clinical support.
“We’ve...
Abbott agrees to pay $385M to settle infant formula case
September 15, 2026HME News Staff
ABBOTT PARK, Ill. – Abbott will pay $385 million to resolve a previously disclosed investigation and lawsuit brought by the U.S. Department of Justice (DOJ), as well as lawsuits filed by certain relators and the attorneys general of several states, relating to its 2022 recall of powdered infant formula manufactured at its Sturgis, Mich., facility.
The settlement, the company says, does not represent any finding of fault or liability.
Abbott also noted, in relation to the settlement:
The...
NCPA offers ‘how-to’ strategy at annual convention
September 11, 2026Tracy Orzel
ALEXANDRIA, Va. – What works for one independent pharmacy rarely works for another, which is why the National Community Pharmacists Association (NCPA) is shaping its 2026 Annual Convention around the art of translation.
The convention will feature new “how-to” booths in the Expo Hall, where attendees can seek peer-to-peer, one-on-one guidance on subjects ranging from financial statements to becoming a wellness destination.
“A lot of the discussion we have with attendees...